BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 22713797)

  • 41. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of sentinel lymph node biopsy and adjuvant interferon treatment in thick (>4 mm) cutaneous melanoma: an observational study.
    Morera-Sendra N; Tejera-Vaquerizo A; Traves V; Requena C; Bolumar I; Pla A; Vázquez C; Soriano V; Nagore E
    Eur J Dermatol; 2016; 26(1):34-48. PubMed ID: 27023017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.
    Ito T; Moroi Y; Oba J; Nakahara T; Takeuchi S; Uchi H; Takahara M; Masuda T; Furue M
    Melanoma Res; 2012 Feb; 22(1):38-44. PubMed ID: 22108607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older.
    Sabel MS; Kozminski D; Griffith K; Chang AE; Johnson TM; Wong S
    Ann Surg Oncol; 2015 Jul; 22(7):2112-9. PubMed ID: 25834993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
    Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
    Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients.
    Kibrité A; Milot H; Douville P; Gagné ÉJ; Labonté S; Friede J; Morin F; Ouellet JF; Claveau J
    Am J Surg; 2016 Jan; 211(1):89-94. PubMed ID: 26275921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
    Chagpar RB; Ross MI; Reintgen DS; Edwards MJ; Scoggins CR; Martin RC; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; McMasters KM
    J Surg Res; 2007 Nov; 143(1):164-8. PubMed ID: 17950088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of sentinel lymph node biopsy in patients with thick melanoma. A single centre experience.
    Kelly J; Redmond HP
    Surgeon; 2012 Apr; 10(2):65-70. PubMed ID: 22385526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.
    Reintgen M; Murray L; Akman K; Giuliano R; Lozicki A; Shivers S; Reintgen D
    Ann Surg Oncol; 2013 Feb; 20(2):668-74. PubMed ID: 23054112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes.
    Ribero S; Quaglino P; Osella-Abate S; Sanlorenzo M; Senetta R; Macrì L; Savoia P; Macripò G; Sapino A; Bernengo MG
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1132-7. PubMed ID: 22998598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.
    Quaglino P; Ribero S; Osella-Abate S; Macrì L; Grassi M; Caliendo V; Asioli S; Sapino A; Macripò G; Savoia P; Bernengo MG
    Surg Oncol; 2011 Dec; 20(4):259-64. PubMed ID: 21145730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
    Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unique prognostic factors in acral lentiginous melanoma.
    Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
    Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
    Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
    J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.